Feika Bian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Feika Bian has a total of 110 co-authors. Here are the top co-authors by number of shared publications:
- Yuanjin Zhao
Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 210096, China
18 shared publications Yu Wang
Wenzhou Institute
11 shared publicationsLingyu Sun
Cardiovascular Medical Center, The Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China
9 shared publicationsLijun Cai
Department of Rheumatology and Immunology Nanjing Drum Tower Hospital School of Biological Science and Medical Engineering Southeast University Nanjing 210096 China
6 shared publications- Lingyu Sun
Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China
5 shared publications - Huan Wang
The Eighth Affiliated Hospital Sun Yat‐Sen University Shenzhen China
3 shared publications
Latest Publications
- Open Access
- 29 June 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Myocardial mechanics displaying on visual structural color hydrogel microcolumn arrays
Cellular mechanics play significant roles in biological processes from cellular level to tissue level. Great efforts have been committed to developing simp
- 29 June 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Open AccessMyocardial mechanics displaying on visual structural color hydrogel microcolumn arrays
Cellular mechanics play significant roles in biological processes from cellular level to tissue level. Great efforts have been committed to developing simp
- 17 February 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (8) , 6272-6279
Wettable Porous Arrays with Structural Color Barcodes Integration for Multiplex Urinary Tract Infection Bacteria Screening
Urinary tract infection (UTI) is one of the most common bacterial infections in clinical practice and is a potentially life-threatening infection with high morbidity, recurrence, and mortality rates. High-sensitivity multiplexed biomarker detection is crucial for the early diagnosis and treatment of UTI. Digital nucleic acid amplification technologies (dNAATs) offer highly sensitive molecular characterization by isolating individual template molecules and amplifying them separately. However, multiplex analysis with dNAATs often requires parallel amplification, which is time-consuming and labor-intensive. Here, we present a novel multiplex detection method that integrates structural color barcodes into superhydrophilic porous arrays. This method enables the sensitive detection of multiple targets simultaneously in a highly efficient manner. The excellent hydrophilicity of the microwells allows the reaction solution to fill each well, ensuring random and complete isolation of the nucleic acid molecules. The amplification reactions occur independently in each unit, enabling the absolute quantification of nucleic acids. The structural color barcodes fixed in the microwells have stable reflection peaks and large surface areas, serving as encoding carriers based on their distinct reflection wavelengths. This enables the screening of multiplexed UTI bacteria to be performed quickly, accurately, and reproducibly. By using different probes on the color barcodes, we were able to detect single and multiple UTI pathogens with high sensitivity. The results demonstrate that the integrated porous array platform with structural color barcodes realized the highly sensitive detection and screening of UTI bacteria, which has great potential in multiplex biomolecule detection and early diagnosis of infections.
- 17 February 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (8) , 6272-6279
Wettable Porous Arrays with Structural Color Barcodes Integration for Multiplex Urinary Tract Infection Bacteria Screening
Urinary tract infection (UTI) is one of the most common bacterial infections in clinical practice and is a potentially life-threatening infection with high morbidity, recurrence, and mortality rates. High-sensitivity multiplexed biomarker detection is crucial for the early diagnosis and treatment of UTI. Digital nucleic acid amplification technologies (dNAATs) offer highly sensitive molecular characterization by isolating individual template molecules and amplifying them separately. However, multiplex analysis with dNAATs often requires parallel amplification, which is time-consuming and labor-intensive. Here, we present a novel multiplex detection method that integrates structural color barcodes into superhydrophilic porous arrays. This method enables the sensitive detection of multiple targets simultaneously in a highly efficient manner. The excellent hydrophilicity of the microwells allows the reaction solution to fill each well, ensuring random and complete isolation of the nucleic acid molecules. The amplification reactions occur independently in each unit, enabling the absolute quantification of nucleic acids. The structural color barcodes fixed in the microwells have stable reflection peaks and large surface areas, serving as encoding carriers based on their distinct reflection wavelengths. This enables the screening of multiplexed UTI bacteria to be performed quickly, accurately, and reproducibly. By using different probes on the color barcodes, we were able to detect single and multiple UTI pathogens with high sensitivity. The results demonstrate that the integrated porous array platform with structural color barcodes realized the highly sensitive detection and screening of UTI bacteria, which has great potential in multiplex biomolecule detection and early diagnosis of infections.
- 30 January 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (5) , 7900-7909
Primary Human Gastric Cancer Cells Integrated Hydrogel Microcapsules for Personalized Drug Screening
Organ-on-a-chip is highly valuable for tumor drug screening, but further exploration in gastric cancer is needed. Here, we propose an innovative platform to cultivate primary gastric cancer cells using microfluidic encapsulation, enabling three-dimensional (3D) tumor growth and clinical drug assessment. We employ microfluidic electrospray technology to mix human primary gastric cancer cells with carboxymethyl cellulose and encapsulate them within alginate core-shell microcapsules. Tumor cells spontaneously form spheroids and proliferate rapidly. These tumor spheroids display multiple characteristics of natural tumors and exhibit heterogeneity within them. Subsequently, microcapsules containing tumor spheroids are combined with a microfluidic chip that is designed with a gradient generator and a culture chamber. This platform enables dynamic perfusion of various chemotherapy drug solutions and the high-throughput generation of drug concentration gradients to assess tumor spheroid sensitivity to these drugs. The findings reveal variations in drug sensitivity among gastric cancer spheroids from different patients. Notably, the drug sensitivity profiles obtained from the tumor spheroid assays show significant consistency with the actual clinical responses of the corresponding patients. These outcomes underscore the potential of integrating microcapsule-cultured tumor spheroid models with microfluidic technology to create a dependable and precise drug evaluation platform for clinical applications in gastric cancer treatment.
- 30 January 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (5) , 7900-7909
Primary Human Gastric Cancer Cells Integrated Hydrogel Microcapsules for Personalized Drug Screening
Organ-on-a-chip is highly valuable for tumor drug screening, but further exploration in gastric cancer is needed. Here, we propose an innovative platform to cultivate primary gastric cancer cells using microfluidic encapsulation, enabling three-dimensional (3D) tumor growth and clinical drug assessment. We employ microfluidic electrospray technology to mix human primary gastric cancer cells with carboxymethyl cellulose and encapsulate them within alginate core-shell microcapsules. Tumor cells spontaneously form spheroids and proliferate rapidly. These tumor spheroids display multiple characteristics of natural tumors and exhibit heterogeneity within them. Subsequently, microcapsules containing tumor spheroids are combined with a microfluidic chip that is designed with a gradient generator and a culture chamber. This platform enables dynamic perfusion of various chemotherapy drug solutions and the high-throughput generation of drug concentration gradients to assess tumor spheroid sensitivity to these drugs. The findings reveal variations in drug sensitivity among gastric cancer spheroids from different patients. Notably, the drug sensitivity profiles obtained from the tumor spheroid assays show significant consistency with the actual clinical responses of the corresponding patients. These outcomes underscore the potential of integrating microcapsule-cultured tumor spheroid models with microfluidic technology to create a dependable and precise drug evaluation platform for clinical applications in gastric cancer treatment.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 151 (17) , 4878-4901
Developing Digital PCR Technologies Based on Wettable Substrates
Since the invention of polymerase chain reaction (PCR) in 1985, the technology has evolved from qualitative PCR to real-time fluorescent quantitative PCR (qPCR) and ultimately to digital PCR (dPCR). Notably,...
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 151 (17) , 4878-4901
Developing Digital PCR Technologies Based on Wettable Substrates
Since the invention of polymerase chain reaction (PCR) in 1985, the technology has evolved from qualitative PCR to real-time fluorescent quantitative PCR (qPCR) and ultimately to digital PCR (dPCR). Notably,...
- Open Access
- 9 September 2025
- Published by Wiley in Smart Medicine
- Vol. 4 (3)
Antibacterial and Proangiogenic Hydrogel Microneedle Patches for Wound Healing
Wounds represent a global and challenging healthcare issue, resulting in a cascade of consequences. Despite the widespread application of existing wound dressings, their performance and efficacy are significantly limited in terms of biocompatible matrices and functionalization for promoting vascularization and antimicrobial activity. In this study, we propose a drug‐loaded microneedle based on a copolymer hydrogel composed of methacrylated chitosan and polyethylene glycol diacrylate incorporating antimicrobial peptide and vascular endothelial growth factor. These microneedles were applied to wounds where their degradation facilitated the release of the loaded drugs to exert antibacterial and angiogenic effects. In vitro experiments demonstrated that our microneedles exhibit uniform morphology, good structural integrity, controlled drug release, and other excellent properties. Upon interaction with cells and bacteria, they displayed biocompatibility and superior dual antibacterial capabilities. In an in vivo infectious wound model, the microneedles significantly promoted wound healing through their antibacterial and angiogenic effects, showing clear advantages over the control group. Thus, these drug‐loaded microneedles serve as a multifunctional dressing, offering a promising novel strategy for wound repair.
- 9 September 2025
- Published by Wiley in Smart Medicine
- Vol. 4 (3)
Open AccessAntibacterial and Proangiogenic Hydrogel Microneedle Patches for Wound Healing
Wounds represent a global and challenging healthcare issue, resulting in a cascade of consequences. Despite the widespread application of existing wound dressings, their performance and efficacy are significantly limited in terms of biocompatible matrices and functionalization for promoting vascularization and antimicrobial activity. In this study, we propose a drug‐loaded microneedle based on a copolymer hydrogel composed of methacrylated chitosan and polyethylene glycol diacrylate incorporating antimicrobial peptide and vascular endothelial growth factor. These microneedles were applied to wounds where their degradation facilitated the release of the loaded drugs to exert antibacterial and angiogenic effects. In vitro experiments demonstrated that our microneedles exhibit uniform morphology, good structural integrity, controlled drug release, and other excellent properties. Upon interaction with cells and bacteria, they displayed biocompatibility and superior dual antibacterial capabilities. In an in vivo infectious wound model, the microneedles significantly promoted wound healing through their antibacterial and angiogenic effects, showing clear advantages over the control group. Thus, these drug‐loaded microneedles serve as a multifunctional dressing, offering a promising novel strategy for wound repair.
- Open Access
- 1 April 2025
- Published by KEAI Publishing in Bioactive Materials
- Vol. 46, 494-502
Dual physiological responsive structural color hydrogel particles for wound repair
Hydrogel-based patches have demonstrated their values in diabetic wounds repair, particularly those intelligent dressings with continuous repair promoting and monitoring capabilities. Here, we propose a type of dual physiological responsive structural color particles for wound repair. The particles are composed of a hyaluronic acid methacryloyl (HAMA)-sodium alginate (Alg) inverse opal scaffold, filled with oxidized dextran (ODex)/quaternized chitosan (QCS) hydrogel. The photo-polymerized HAMA and ionically cross-linked Ca-Alg constitute to the dual-network hydrogel with stable structural color. Furthermore, the ODex/QCS hydrogel, combined with glucose oxidase (GOX), exhibits pH/glucose dual responsiveness. Moreover, antimmicrobial peptide (AMP) plus vascular endothelial growth factor (VEGF) are comprised within the GOX-doped ODex/QCS hydrogel. In the high-glucose wound environment, GOX catalyzes glucose to generate acidic products, triggering rapid release of AMP and VEGF. Importantly, this process also leads to structural color changes of the particles, offering significant potential for wound monitoring. It has been demonstrated that such particles greatly promote the healing progress of diabetic wound in vivo. These results indicate that the present dual responsive particles would find valuable applications in diabetic wounds repair and the associated areas.
- 1 April 2025
- Published by KEAI Publishing in Bioactive Materials
- Vol. 46, 494-502
Open AccessDual physiological responsive structural color hydrogel particles for wound repair
Hydrogel-based patches have demonstrated their values in diabetic wounds repair, particularly those intelligent dressings with continuous repair promoting and monitoring capabilities. Here, we propose a type of dual physiological responsive structural color particles for wound repair. The particles are composed of a hyaluronic acid methacryloyl (HAMA)-sodium alginate (Alg) inverse opal scaffold, filled with oxidized dextran (ODex)/quaternized chitosan (QCS) hydrogel. The photo-polymerized HAMA and ionically cross-linked Ca-Alg constitute to the dual-network hydrogel with stable structural color. Furthermore, the ODex/QCS hydrogel, combined with glucose oxidase (GOX), exhibits pH/glucose dual responsiveness. Moreover, antimmicrobial peptide (AMP) plus vascular endothelial growth factor (VEGF) are comprised within the GOX-doped ODex/QCS hydrogel. In the high-glucose wound environment, GOX catalyzes glucose to generate acidic products, triggering rapid release of AMP and VEGF. Importantly, this process also leads to structural color changes of the particles, offering significant potential for wound monitoring. It has been demonstrated that such particles greatly promote the healing progress of diabetic wound in vivo. These results indicate that the present dual responsive particles would find valuable applications in diabetic wounds repair and the associated areas.
- 28 March 2025
- Published by American Chemical Society (ACS) in ACS Materials Letters
- Vol. 7 (4) , 1626-1645
Artificial Human Blood Vessels for Tissue Engineering
- 28 March 2025
- Published by American Chemical Society (ACS) in ACS Materials Letters
- Vol. 7 (4) , 1626-1645
Artificial Human Blood Vessels for Tissue Engineering
- 13 March 2025
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 150 (8) , 1553-1562
Microfluidic magnetic droplet-based chemiluminescence enzyme immunoassay for multiplex sepsis biomarker screening
Sepsis is a systemic inflammatory response syndrome caused by infection, requiring the joint detection of multiplex biomarkers for specific diagnosis. Here, we present a chemiluminescence enzyme immunoassay based on microfluidic magnetic droplets for multiplex sepsis biomarker screening. The droplet-based chemiluminescence enzyme immunoassay (CLIA) technology utilizes multicolor-encoded microspheres to distinguish biomarkers and mesoporous silica-loaded enzymes for signal amplification and catalytic fluorescent substrates. Additionally, digital immunoassays via Poisson distribution in the generated droplets provide a reliable quantitative strategy for detecting rare targets. This method achieves high sensitivity, low interference, and simultaneous detection with satisfactory specificity of various sepsis biomarkers, such as procalcitonin (PCT), interleukin-6 (IL-6), and C-reactive protein (CRP). These features demonstrate that the microfluidic droplet-based CLIA method has great potential for broader applications in multiplex biomolecule detection and early disease diagnosis.
- 13 March 2025
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 150 (8) , 1553-1562
Microfluidic magnetic droplet-based chemiluminescence enzyme immunoassay for multiplex sepsis biomarker screening
Sepsis is a systemic inflammatory response syndrome caused by infection, requiring the joint detection of multiplex biomarkers for specific diagnosis. Here, we present a chemiluminescence enzyme immunoassay based on microfluidic magnetic droplets for multiplex sepsis biomarker screening. The droplet-based chemiluminescence enzyme immunoassay (CLIA) technology utilizes multicolor-encoded microspheres to distinguish biomarkers and mesoporous silica-loaded enzymes for signal amplification and catalytic fluorescent substrates. Additionally, digital immunoassays via Poisson distribution in the generated droplets provide a reliable quantitative strategy for detecting rare targets. This method achieves high sensitivity, low interference, and simultaneous detection with satisfactory specificity of various sepsis biomarkers, such as procalcitonin (PCT), interleukin-6 (IL-6), and C-reactive protein (CRP). These features demonstrate that the microfluidic droplet-based CLIA method has great potential for broader applications in multiplex biomolecule detection and early disease diagnosis.
- 14 November 2024
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 269, 116944
Assessment of drug treatment response using primary human colon cancer cell spheroids cultivated in a microfluidic mixer chip
- 14 November 2024
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 269, 116944
Assessment of drug treatment response using primary human colon cancer cell spheroids cultivated in a microfluidic mixer chip